Drug safety, drug quality, drug analysis
Author:
- 1 September 2008
- journal article
- review article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 48 (2) , 247-253
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Is HPLC assay for drug substance a useful quality control attribute?Journal of Pharmaceutical and Biomedical Analysis, 2007
- Pharmaceutical impurities: Regulatory perspective for Abbreviated New Drug Applications☆☆☆Advanced Drug Delivery Reviews, 2007
- Improving method capability of a drug substance HPLC assayJournal of Pharmaceutical and Biomedical Analysis, 2006
- Analytical methodologies for discovering and profiling degradation-related impuritiesTrAC Trends in Analytical Chemistry, 2006
- The importance of impurity analysis in pharmaceutical products: an integrated approachAccreditation and Quality Assurance, 2006
- Official USP Reference Standards: Metrology concepts, overview, and scientific issues and opportunitiesJournal of Pharmaceutical and Biomedical Analysis, 2005
- Validation in pharmaceutical analysisJournal of Pharmaceutical and Biomedical Analysis, 2005
- The sacred cow: the questionable role of assay methods in characterising the quality of bulk pharmaceuticalsJournal of Pharmaceutical and Biomedical Analysis, 2005
- Estimation of impurity profiles of drugs and related materials: Part 19: Theme with variations. Identification of impurities in 3-oxosteroidsJournal of Pharmaceutical and Biomedical Analysis, 1998
- Estimation of impurity profiles of drugs and related materials part 14: The role of HPLC/diode-array UV spectroscopy in the identification of minor components (impurities, degradation products, metabolites) in various matricesJournal of Pharmaceutical and Biomedical Analysis, 1995